Correlation Between Virax Biolabs and Immix Biopharma
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Immix Biopharma, you can compare the effects of market volatilities on Virax Biolabs and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Immix Biopharma.
Diversification Opportunities for Virax Biolabs and Immix Biopharma
0.9 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Virax and Immix is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Immix Biopharma go up and down completely randomly.
Pair Corralation between Virax Biolabs and Immix Biopharma
Given the investment horizon of 90 days Virax Biolabs Group is expected to under-perform the Immix Biopharma. In addition to that, Virax Biolabs is 1.43 times more volatile than Immix Biopharma. It trades about -0.11 of its total potential returns per unit of risk. Immix Biopharma is currently generating about 0.11 per unit of volatility. If you would invest 163.00 in Immix Biopharma on August 24, 2024 and sell it today you would earn a total of 16.00 from holding Immix Biopharma or generate 9.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Immix Biopharma
Performance |
| Timeline |
| Virax Biolabs Group |
| Immix Biopharma |
Virax Biolabs and Immix Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Immix Biopharma
The main advantage of trading using opposite Virax Biolabs and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Neurobo Pharmaceuticals |
| Immix Biopharma vs. ZyVersa Therapeutics | Immix Biopharma vs. Hepion Pharmaceuticals | Immix Biopharma vs. Cns Pharmaceuticals | Immix Biopharma vs. Sonnet Biotherapeutics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |